These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2688213)

  • 1. Is there a case for PAF antagonists in the treatment of ischemic states?
    Braquet P; Paubert-Braquet M; Koltai M; Bourgain R; Bussolino F; Hosford D
    Trends Pharmacol Sci; 1989 Jan; 10(1):23-30. PubMed ID: 2688213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnopharmacology and the development of natural PAF antagonists as therapeutic agents.
    Braquet P; Hosford D
    J Ethnopharmacol; 1991 Apr; 32(1-3):135-9. PubMed ID: 1881152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of tissue injury and altered cardiovascular performance by platelet-activating factor: relevance to multiple systems organ failure.
    Lefer AM
    Crit Care Clin; 1989 Apr; 5(2):331-52. PubMed ID: 2650821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of platelet-activating factor antagonist on ischemia-induced liver injury in rats.
    Wang KS; Monden M; Kanai T; Gotoh M; Umeshita K; Ukei T; Mori T
    Surgery; 1993 Jan; 113(1):76-83. PubMed ID: 8417492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor antagonists.
    Saunders RN; Handley DA
    Annu Rev Pharmacol Toxicol; 1987; 27():237-55. PubMed ID: 3555317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor and cytokine interactions in shock.
    Hosford D; Paubert-Braquet M; Braquet P
    Resuscitation; 1989 Dec; 18(2-3):207-18. PubMed ID: 2555874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term protective effect of UR-12670 after warm renal ischemia in uninephrectomized rats.
    Torras J; Cruzado JM; Riera M; Condom E; Duque N; Herrero I; Merlos M; Espinosa L; Lloberas N; Egido J; Grinyó JM
    Kidney Int; 1999 Nov; 56(5):1798-808. PubMed ID: 10571788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet activating factor (PAF). A review of its effects, antagonists and possible future clinical implications (Part I).
    Koltai M; Hosford D; Guinot P; Esanu A; Braquet P
    Drugs; 1991 Jul; 42(1):9-29. PubMed ID: 1718687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor antagonists reduce excitotoxic damage in cultured neurons from embryonic chick telencephalon and protect the rat hippocampus and neocortex from ischemic injury in vivo.
    Prehn JH; Krieglstein J
    J Neurosci Res; 1993 Feb; 34(2):179-88. PubMed ID: 8095559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of PAF antagonists in experimental models. Therapeutical perspectives].
    Desquand S
    Therapie; 1993; 48(6):585-97. PubMed ID: 8091344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pooling of blood in postischemic shock is modulated by platelet-activating factor (PAF).
    Sagach VF; Dmitrieva AV; Braquet P
    Lipids; 1991 Dec; 26(12):1400-3. PubMed ID: 1819740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor (PAF)-antagonists of natural origin.
    Singh P; Singh IN; Mondal SC; Singh L; Garg VK
    Fitoterapia; 2013 Jan; 84():180-201. PubMed ID: 23160091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of platelet activating factor and its antagonists in bronchial asthma].
    Massion PB; Frans A
    Rev Pneumol Clin; 1992; 48(2):49-57. PubMed ID: 1384101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists.
    Wallace JL; Steel G; Whittle BJ; Lagente V; Vargaftig B
    Gastroenterology; 1987 Oct; 93(4):765-73. PubMed ID: 3305134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAF/cytokine auto-generated feedback networks in microvascular immune injury: consequences in shock, ischemia and graft rejection.
    Braquet P; Paubert-Braquet M; Bourgain RH; Bussolino F; Hosford D
    J Lipid Mediat; 1989; 1(2):75-112. PubMed ID: 2519889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of platelet-activating factor (PAF) in cerebral post-ischemic phase in Mongolian gerbils.
    Spinnewyn B; Blavet N; Clostre F; Bazan N; Braquet P
    Prostaglandins; 1987 Sep; 34(3):337-49. PubMed ID: 3432553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of platelet-activating factor (PAF) in septic shock and priming as indicated by the effect of hetrazepinoic PAF antagonists.
    Heuer HO
    Lipids; 1991 Dec; 26(12):1369-73. PubMed ID: 1819735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of BN 50727 on pathological findings and tissue platelet activating factor levels during ileal ischemia in newborn piglets.
    de Boissieu D; Canarelli JP; Cordonnier C; Richard S; Léké A; Tarrade T; Postel JP; Dupont C
    J Pediatr Surg; 1996 Dec; 31(12):1675-9. PubMed ID: 8986985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophils accentuate renal cold ischemia-reperfusion injury. Dose-dependent protective effect of a platelet-activating factor receptor antagonist.
    Riera M; Torras J; Herrero I; Valles J; Paubert-Braquet M; Cruzado JM; Alsina J; Grinyo JM
    J Pharmacol Exp Ther; 1997 Feb; 280(2):786-94. PubMed ID: 9023292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of platelet activating factor in kidney transplant rejection in the rat.
    Butterly DW; Spurney RF; Ruiz P; Pirotzky E; Braquet P; Coffman TM
    Kidney Int; 1995 Aug; 48(2):337-43. PubMed ID: 7564100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.